{"id":997,"date":"2022-08-08T01:39:11","date_gmt":"2022-08-08T05:39:11","guid":{"rendered":"https:\/\/aafa.org\/?page_id=997"},"modified":"2026-06-29T11:32:06","modified_gmt":"2026-06-29T15:32:06","slug":"patient-focused-drug-development-for-atopic-dermatitis","status":"publish","type":"page","link":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development-for-atopic-dermatitis\/","title":{"rendered":"Patient Focused Drug Development: Eczema"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Research T-Hero Section&#8221; module_class=&#8221;hero tert&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; background_image=&#8221;https:\/\/aafa.org\/wp-content\/uploads\/2022\/07\/AAFA-Website_Tertiary_Research.jpg&#8221; background_position=&#8221;top_right&#8221; custom_padding=&#8221;1%||1%||true|false&#8221; saved_tabs=&#8221;all&#8221; locked=&#8221;off&#8221; collapsed=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; background_enable_image=&#8221;off&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;bottom_left&#8221; background_horizontal_offset=&#8221;0%&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;2%||0px||false|false&#8221; hover_enabled=&#8221;0&#8243; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; collapsed=&#8221;off&#8221; sticky_enabled=&#8221;0&#8243;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;Nav Parent Title&#8221; module_class=&#8221;tert-parent&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_2_font=&#8221;|600|||||||&#8221; header_2_text_align=&#8221;left&#8221; header_2_text_color=&#8221;#FFFFFF&#8221; header_2_font_size=&#8221;32px&#8221; custom_margin=&#8221;||0px||false|false&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h2>Patient Focused Drug Development: Eczema<\/h2>\n<p>[\/et_pb_text][et_pb_code admin_label=&#8221;Breadcrumbs&#8221; module_class=&#8221;bcrumb&#8221; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; text_orientation=&#8221;left&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;||||false|false&#8221; custom_css_main_element=&#8221;font-size:16px;||color: #fff;&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Main Content&#8221; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;2%||2%||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;2_3,1_3&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_post_title meta=&#8221;off&#8221; featured_image=&#8221;off&#8221; admin_label=&#8221;Page Title&#8221; module_class=&#8221;tert-content&#8221; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; title_font=&#8221;|600|||||||&#8221; title_text_align=&#8221;left&#8221; title_text_color=&#8221;#008c99&#8243; title_font_size=&#8221;39px&#8221; background_enable_image=&#8221;off&#8221; background_size=&#8221;contain&#8221; background_position=&#8221;center_left&#8221; module_alignment=&#8221;left&#8221; custom_margin=&#8221;||0px||false|false&#8221; custom_padding=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_post_title][et_pb_text admin_label=&#8221; Intro Content&#8221; module_class=&#8221;secondary-intro&#8221; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#505050&#8243; text_font_size=&#8221;24px&#8221; text_line_height=&#8221;1.5em&#8221; header_2_font=&#8221;|600|||||||&#8221; header_2_text_color=&#8221;#008c99&#8243; header_2_font_size=&#8221;39px&#8221; custom_margin=&#8221;||3%||false|false&#8221; global_colors_info=&#8221;{}&#8221;]Treatment priorities of people living with atopic dermatitis (AD)\u2014or eczema\u2014 are at the core of a special initiative called \u201cMore Than Skin Deep.&#8221; [\/et_pb_text][et_pb_text admin_label=&#8221;Page Content&#8221; module_class=&#8221;secondary-intro&#8221; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#505050&#8243; text_line_height=&#8221;1.5em&#8221; header_2_font=&#8221;|600|||||||&#8221; header_2_text_color=&#8221;#008c99&#8243; header_2_font_size=&#8221;39px&#8221; custom_margin=&#8221;||3%||false|false&#8221; global_colors_info=&#8221;{}&#8221;]AAFA partnered with four nonprofit organizations to create a series of opportunities for your perspective to inform and shape development of drugs and medical devices designed to treat eczema.<\/p>\n<p>As part of the collaboration, we hosted a patient-focused drug development (PFDD) meeting on September 23, 2019 in the Washington, D.C. area. It provided the eczema community an opportunity to speak directly to Food and Drug Administration (FDA) staff, representatives of pharmaceutical and medical device companies, and other key stakeholders.<\/p>\n<p>This initiative was the first of its kind for eczema . Your voice and perspectives are essential for us to demonstrate that eczema is \u201cmore than skin deep.&#8221;[\/et_pb_text][et_pb_text admin_label=&#8221;Download PDFs&#8221; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#505050&#8243; link_font=&#8221;||||on||||&#8221; link_text_color=&#8221;#008c99&#8243; header_4_font=&#8221;|600|||||||&#8221; header_4_text_color=&#8221;#008c99&#8243; background_image=&#8221;https:\/\/aafa.org\/wp-content\/uploads\/2022\/06\/small_swoosh_BG.png&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_horizontal_offset=&#8221;0%&#8221; background_vertical_offset=&#8221;0%&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Download PDFs<\/h4>\n<p><a title=\"more-than-skin-deep-voice-of-the-patient-report\" href=\"\/wp-content\/uploads\/2022\/08\/more-than-skin-deep-voice-of-the-patient-report.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">More Than Skin Deep<\/a><img decoding=\"async\" src=\"\/wp-content\/uploads\/2022\/08\/pdf-24x24-1.png\" alt=\"Download PDF\" loading=\"lazy\" \/>.[\/et_pb_text][et_pb_code admin_label=&#8221;Print&#8221; module_id=&#8221;print&#8221; module_class=&#8221;clearfix&#8221; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; global_module=&#8221;5156&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;]<a href=\"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development-for-atopic-dermatitis\/print\/\" rel=\"nofollow\" title=\"Print post\"><svg class=\"WP-PrintIcon wp-print-icon\" width=\"16\" height=\"16\" viewbox=\"0 0 20 20\" fill=\"currentColor\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M6 2h8v4H6z\" \/><path d=\"M3 7h14v7h-3v-3H6v3H3z\" \/><path d=\"M6 12h8v6H6z\" \/><\/svg> Print post<\/a> [\/et_pb_code][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;6%||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text ul_type=&#8221;none&#8221; disabled_on=&#8221;on|on|on&#8221; admin_label=&#8221;Side Nav &#8211; PFDD&#8221; module_class=&#8221;sidenav&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#008C99&#8243; text_font_size=&#8221;14px&#8221; link_text_align=&#8221;left&#8221; link_text_color=&#8221;#008C99&#8243; link_font_size=&#8221;16px&#8221; link_line_height=&#8221;1.7em&#8221; ul_text_color=&#8221;#008C99&#8243; ul_font_size=&#8221;16px&#8221; ul_line_height=&#8221;1.7em&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_align=&#8221;left&#8221; header_4_text_color=&#8221;#008C99&#8243; header_4_font_size=&#8221;16px&#8221; header_4_line_height=&#8221;1.7em&#8221; background_color=&#8221;#F5EDDF&#8221; custom_padding=&#8221;6%|6%|6%|6%|true|true&#8221; border_color_top=&#8221;#008C99&#8243; global_module=&#8221;10080&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221; link_text_color__hover_enabled=&#8221;on|hover&#8221; link_text_color__hover=&#8221;#692D87&#8243;]<\/p>\n<h4><a href=\"\/asthma-allergy-research\/our-research\/patient-focused-drug-development\/\">Patient-Focused Drug Development<\/a><\/h4>\n<ul>\n<li><a href=\"\/asthma-allergy-research\/our-research\/patient-focused-drug-development-asthma\/\">Asthma<\/a><\/li>\n<li><a href=\"\/asthma-allergy-research\/our-research\/patient-focused-drug-development-for-atopic-dermatitis\/\">Eczema<\/a><\/li>\n<li><a href=\"\/asthma-allergy-research\/our-research\/patient-focused-drug-development-food-allergy\/\">Food Allergy<\/a><\/li>\n<\/ul>\n<p>[\/et_pb_text][et_pb_image src=&#8221;https:\/\/aafa.org\/wp-content\/uploads\/2022\/08\/more-than-skin-deep-understanding-eczema.png&#8221; alt=&#8221;Understanding living with eczema report&#8221; title_text=&#8221;more-than-skin-deep-understanding-eczema&#8221; url=&#8221;https:\/\/aafa.org\/wp-content\/uploads\/2022\/08\/more-than-skin-deep-voice-of-the-patient-report.pdf&#8221; url_new_window=&#8221;on&#8221; admin_label=&#8221;More Than Skin Deep Report Image&#8221; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; global_module=&#8221;13165&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_button button_url=&#8221;\/wp-content\/uploads\/2022\/08\/more-than-skin-deep-voice-of-the-patient-report.pdf&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;View Full Report&#8221; button_alignment=&#8221;center&#8221; disabled_on=&#8221;off|off|off&#8221; admin_label=&#8221;More Than Skin Deep Report Button&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_bg_color=&#8221;#28BDBA&#8221; button_font=&#8221;|600|||||||&#8221; button_use_icon=&#8221;off&#8221; custom_margin=&#8221;6%||||false|false&#8221; custom_css_main_element=&#8221;width:100%;&#8221; global_module=&#8221;792&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][et_pb_text disabled_on=&#8221;on|on|on&#8221; admin_label=&#8221;Racial Justice Blurb&#8221; module_class=&#8221;sidebar-blurb&#8221; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#505050&#8243; text_font_size=&#8221;16px&#8221; link_font=&#8221;|600||on|||||&#8221; link_text_align=&#8221;left&#8221; link_text_color=&#8221;#692d87&#8243; link_font_size=&#8221;16px&#8221; header_4_font=&#8221;|600|||||||&#8221; header_4_text_align=&#8221;left&#8221; header_4_text_color=&#8221;#008c99&#8243; header_4_font_size=&#8221;20px&#8221; background_image=&#8221;https:\/\/aafa.org\/wp-content\/uploads\/2022\/06\/teal_scribble.png&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; custom_margin=&#8221;8%||8%||true|false&#8221; custom_padding=&#8221;2%||2%||true|false&#8221; global_module=&#8221;4735&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>AAFA&#8217;s Commitment to Racial Justice<\/h4>\n<p>Over the past 15 years, there have been moderate advances in U.S. public policy, health care and research, but racial gaps in asthma outcomes have not changed. Minority groups continue to bear disproportionate hardship in managing asthma.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Blog Feed &#8211; Research&#8221; module_class=&#8221;int-blog-ftr&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F5EDDF&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;2%||2%||false|false&#8221; top_divider_color=&#8221;#28BDBA&#8221; top_divider_flip=&#8221;horizontal&#8221; bottom_divider_color=&#8221;#28BDBA&#8221; bottom_divider_height=&#8221;50px&#8221; bottom_divider_arrangement=&#8221;above_content&#8221; global_module=&#8221;9338&#8243; saved_tabs=&#8221;all&#8221; locked=&#8221;off&#8221; collapsed=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;0px||0px||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;Related Content&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#505050&#8243; link_font=&#8221;||||on|||#008c99|&#8221; link_text_color=&#8221;#008c99&#8243; header_2_font=&#8221;|600|||||||&#8221; header_2_text_color=&#8221;#008c99&#8243; header_2_font_size=&#8221;39px&#8221; header_3_font=&#8221;|600|||||||&#8221; header_3_text_align=&#8221;left&#8221; header_3_text_color=&#8221;#008c99&#8243; header_3_font_size=&#8221;28px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Related Content<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_3,1_3,1_3&#8243; use_custom_gutter=&#8221;on&#8221; gutter_width=&#8221;2&#8243; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||1%||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/aafa.org\/wp-content\/uploads\/2025\/09\/2025-asthma-capitals-general-BT.jpg&#8221; alt=&#8221;Chick-fil-A product change alert&#8221; title_text=&#8221;2025-asthma-capitals-general-BT&#8221; url=&#8221;https:\/\/community.aafa.org\/blog\/2025-asthma-capitals-report-locations-impact-on-asthma&#8221; show_bottom_space=&#8221;off&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; background_enable_image=&#8221;off&#8221; width=&#8221;100%&#8221; custom_margin=&#8221;0px||0px||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text admin_label=&#8221;Blog Link Text&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|600|||||||&#8221; text_text_color=&#8221;#28BDBA&#8221; text_font_size=&#8221;16px&#8221; text_line_height=&#8221;1.6em&#8221; link_font=&#8221;|600|||||||&#8221; link_text_align=&#8221;left&#8221; link_text_color=&#8221;#28BDBA&#8221; link_font_size=&#8221;16px&#8221; link_line_height=&#8221;1.6em&#8221; background_color=&#8221;#FFFFFF&#8221; height=&#8221;105px&#8221; custom_padding=&#8221;5%|4%|4%|8%|false|false&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;on|hover&#8221; text_text_color__hover=&#8221;#28BDBA&#8221; link_text_color__hover_enabled=&#8221;on|hover&#8221; link_text_color__hover=&#8221;#692D87&#8243;]<\/p>\n<p><a href=\"https:\/\/community.aafa.org\/blog\/2025-asthma-capitals-report-locations-impact-on-asthma\" target=\"_blank\" rel=\"noopener\">2025 Asthma Capitals Report Looks at Location\u2019s Impact on Asthma<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/aafa.org\/wp-content\/uploads\/2026\/03\/2026-allergy-capitals-general-BT.jpg&#8221; alt=&#8221;Various asthma medicines and inhalant equipment&#8221; title_text=&#8221;2026-allergy-capitals-general-BT&#8221; url=&#8221;https:\/\/community.aafa.org\/blog\/allergy-capitals-report-2026-effects-of-climate-change-on-seasonal-allergies&#8221; show_bottom_space=&#8221;off&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; background_enable_image=&#8221;off&#8221; width=&#8221;100%&#8221; custom_margin=&#8221;0px||0px||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text admin_label=&#8221;Blog Link Text&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|600|||||||&#8221; text_text_color=&#8221;#28BDBA&#8221; text_font_size=&#8221;16px&#8221; text_line_height=&#8221;1.6em&#8221; link_font=&#8221;|600|||||||&#8221; link_text_align=&#8221;left&#8221; link_text_color=&#8221;#28BDBA&#8221; link_font_size=&#8221;16px&#8221; link_line_height=&#8221;1.6em&#8221; background_color=&#8221;#FFFFFF&#8221; height=&#8221;105px&#8221; custom_padding=&#8221;5%|4%|4%|8%|false|false&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;on|hover&#8221; text_text_color__hover=&#8221;#28BDBA&#8221; link_text_color__hover_enabled=&#8221;on|hover&#8221; link_text_color__hover=&#8221;#692D87&#8243;]<\/p>\n<p><a href=\"https:\/\/community.aafa.org\/blog\/allergy-capitals-report-2026-effects-of-climate-change-on-seasonal-allergies\" target=\"_blank\" rel=\"noopener\">Allergy Capitals\u00ae Report 2026: Effects of Climate Change Shake Up This Year\u2019s List<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/aafa.org\/wp-content\/uploads\/2025\/04\/state-honor-roll-2025-BT.jpg&#8221; alt=&#8221;Milk Allergy Alert&#8221; title_text=&#8221;state-honor-roll-2025-BT&#8221; url=&#8221;https:\/\/community.aafa.org\/blog\/aafa-2025-state-honor-roll-report&#8221; show_bottom_space=&#8221;off&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; background_enable_image=&#8221;off&#8221; width=&#8221;100%&#8221; custom_margin=&#8221;0px||0px||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text admin_label=&#8221;Blog Link Text&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|600|||||||&#8221; text_text_color=&#8221;#28BDBA&#8221; text_font_size=&#8221;16px&#8221; text_line_height=&#8221;1.6em&#8221; link_font=&#8221;|600|||||||&#8221; link_text_align=&#8221;left&#8221; link_text_color=&#8221;#28BDBA&#8221; link_font_size=&#8221;16px&#8221; link_line_height=&#8221;1.6em&#8221; background_color=&#8221;#FFFFFF&#8221; height=&#8221;105px&#8221; custom_padding=&#8221;5%|4%|4%|8%|false|false&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;on|hover&#8221; text_text_color__hover=&#8221;#28BDBA&#8221; link_text_color__hover_enabled=&#8221;on|hover&#8221; link_text_color__hover=&#8221;#692D87&#8243;]<\/p>\n<p><a href=\"https:\/\/community.aafa.org\/blog\/aafa-2025-state-honor-roll-report\" target=\"_blank\" rel=\"noopener\">AAFA Releases 2025 State Honor Roll\u2122 Report<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;0px||||false|false&#8221; custom_padding=&#8221;0px||0px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;View More Link&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#008C99&#8243; link_font=&#8221;|600||on|||||&#8221; link_text_align=&#8221;right&#8221; link_text_color=&#8221;#008C99&#8243; link_font_size=&#8221;18px&#8221; text_orientation=&#8221;right&#8221; global_colors_info=&#8221;{}&#8221; link_text_color__hover_enabled=&#8221;on|hover&#8221; link_text_color__hover=&#8221;#692D87&#8243;]<\/p>\n<p><a href=\"https:\/\/community.aafa.org\/blog\" target=\"_blank\" rel=\"noopener\">View more blog articles &gt;<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Patient Focused Drug Development: EczemaTreatment priorities of people living with atopic dermatitis (AD)\u2014or eczema\u2014 are at the core of a special initiative called \u201cMore Than Skin Deep.&#8221; AAFA partnered with [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":0,"parent":6195,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-997","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.5 (Yoast SEO v28.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Patient Focused Drug Development for Eczema | AAFA.org<\/title>\n<meta name=\"description\" content=\"AAFA has partnered with four other patient groups to host a Patient Focused Drug Development meeting on September 23rd in the Washington, D.C. area. The meeting will help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development-for-atopic-dermatitis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Patient Focused Drug Development: Eczema\" \/>\n<meta property=\"og:description\" content=\"AAFA has partnered with four other patient groups to host a Patient Focused Drug Development meeting on September 23rd in the Washington, D.C. area. The meeting will help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development-for-atopic-dermatitis\/\" \/>\n<meta property=\"og:site_name\" content=\"Asthma and Allergy Foundation of America\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-29T15:32:06+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Patient Focused Drug Development Meeting for Atopic Dermatitis | AAFA.org\" \/>\n<meta name=\"twitter:description\" content=\"AAFA has partnered with four other patient groups to host a Patient Focused Drug Development meeting on September 23rd in the Washington, D.C. area. The meeting will help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/aafa.org\\\/asthma-allergy-research\\\/our-research\\\/patient-focused-drug-development-for-atopic-dermatitis\\\/\",\"url\":\"https:\\\/\\\/aafa.org\\\/asthma-allergy-research\\\/our-research\\\/patient-focused-drug-development-for-atopic-dermatitis\\\/\",\"name\":\"Patient Focused Drug Development for Eczema | AAFA.org\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/#website\"},\"datePublished\":\"2022-08-08T05:39:11+00:00\",\"dateModified\":\"2026-06-29T15:32:06+00:00\",\"description\":\"AAFA has partnered with four other patient groups to host a Patient Focused Drug Development meeting on September 23rd in the Washington, D.C. area. The meeting will help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/asthma-allergy-research\\\/our-research\\\/patient-focused-drug-development-for-atopic-dermatitis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/aafa.org\\\/asthma-allergy-research\\\/our-research\\\/patient-focused-drug-development-for-atopic-dermatitis\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/aafa.org\\\/asthma-allergy-research\\\/our-research\\\/patient-focused-drug-development-for-atopic-dermatitis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Research and Reports\",\"item\":\"https:\\\/\\\/aafa.org\\\/asthma-allergy-research\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our Research\",\"item\":\"https:\\\/\\\/aafa.org\\\/asthma-allergy-research\\\/our-research\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Patient Focused Drug Development: Eczema\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/aafa.org\\\/#website\",\"url\":\"https:\\\/\\\/aafa.org\\\/\",\"name\":\"Asthma and Allergy Foundation of America\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/aafa.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Patient Focused Drug Development for Eczema | AAFA.org","description":"AAFA has partnered with four other patient groups to host a Patient Focused Drug Development meeting on September 23rd in the Washington, D.C. area. The meeting will help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development-for-atopic-dermatitis\/","og_locale":"en_US","og_type":"article","og_title":"Patient Focused Drug Development: Eczema","og_description":"AAFA has partnered with four other patient groups to host a Patient Focused Drug Development meeting on September 23rd in the Washington, D.C. area. The meeting will help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!","og_url":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development-for-atopic-dermatitis\/","og_site_name":"Asthma and Allergy Foundation of America","article_modified_time":"2026-06-29T15:32:06+00:00","twitter_card":"summary_large_image","twitter_title":"Patient Focused Drug Development Meeting for Atopic Dermatitis | AAFA.org","twitter_description":"AAFA has partnered with four other patient groups to host a Patient Focused Drug Development meeting on September 23rd in the Washington, D.C. area. The meeting will help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development-for-atopic-dermatitis\/","url":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development-for-atopic-dermatitis\/","name":"Patient Focused Drug Development for Eczema | AAFA.org","isPartOf":{"@id":"https:\/\/aafa.org\/#website"},"datePublished":"2022-08-08T05:39:11+00:00","dateModified":"2026-06-29T15:32:06+00:00","description":"AAFA has partnered with four other patient groups to host a Patient Focused Drug Development meeting on September 23rd in the Washington, D.C. area. The meeting will help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!","breadcrumb":{"@id":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development-for-atopic-dermatitis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development-for-atopic-dermatitis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development-for-atopic-dermatitis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Research and Reports","item":"https:\/\/aafa.org\/asthma-allergy-research\/"},{"@type":"ListItem","position":2,"name":"Our Research","item":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/"},{"@type":"ListItem","position":3,"name":"Patient Focused Drug Development: Eczema"}]},{"@type":"WebSite","@id":"https:\/\/aafa.org\/#website","url":"https:\/\/aafa.org\/","name":"Asthma and Allergy Foundation of America","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aafa.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/pages\/997","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/comments?post=997"}],"version-history":[{"count":3,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/pages\/997\/revisions"}],"predecessor-version":[{"id":32632,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/pages\/997\/revisions\/32632"}],"up":[{"embeddable":true,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/pages\/6195"}],"wp:attachment":[{"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/media?parent=997"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}